Cartesian Therapeutics Cash from Financing (TTM) Insights

Cartesian Therapeutics Inc (RNAC)

25.60 +1.17 (+4.79%) USD | NASDAQ | May 03, 16:00

25.47 -0.13 (-0.51%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-13.14M
September 30, 2023	-27.23M
June 30, 2023	-1.825M
March 31, 2023	37.64M
December 31, 2022	39.22M
September 30, 2022	60.37M
June 30, 2022	61.21M
March 31, 2022	33.32M
December 31, 2021	52.90M
September 30, 2021	31.55M
June 30, 2021	51.05M
March 31, 2021	41.11M
December 31, 2020	14.43M
September 30, 2020	83.16M
June 30, 2020	67.24M
March 31, 2020	68.56M
December 31, 2019	105.04M

Date	Value
September 30, 2019	36.59M
June 30, 2019	31.81M
March 31, 2019	31.75M
December 31, 2018	0.697M
September 30, 2018	5.655M
June 30, 2018	12.73M
March 31, 2018	66.37M
December 31, 2017	66.02M
September 30, 2017	63.78M
June 30, 2017	58.80M
March 31, 2017	69.04M
December 31, 2016	67.66M
September 30, 2016	70.55M
June 30, 2016	100.18M
March 31, 2016	42.44M
December 31, 2015	43.91M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-27.23M

Minimum

Sep 2023

105.04M

Maximum

Dec 2019

40.68M

Average

39.22M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks